Skip to main content
Center for U.S. Policy
search
Menu
  • About
  • Issues
  • Initiatives
  • Events
  • Media
  • search
Center for U.S. Policy
Close Search
FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning

FDA Approves Rx Nasal Spray to Reverse Opioid Poisoning

News May 23, 2023
Good Intentions Alone Won’t Reduce Drug Poisonings

Good Intentions Alone Won’t Reduce Drug Poisonings

News May 16, 2023
Health Policy Advocates Petition FDA to Recall Software

Health Policy Advocates Petition FDA to Recall Software

News May 12, 2023
DEA Stonewalls FOIA Request

DEA Stonewalls FOIA Request

CUSP Research, News April 7, 2023
Barnes to Speak at 2023 Rx Summit

Barnes to Speak at 2023 Rx Summit

News April 6, 2023
Model Act Promotes SUD Treatment in EDs

Model Act Promotes SUD Treatment in EDs

News March 22, 2023
DEA Proposes Rules for Permanent Telemedicine Flexibilities

DEA Proposes Rules for Permanent Telemedicine Flexibilities

News March 1, 2023
Millennium Health Report on Polysubstance Use in 2022

Millennium Health Report on Polysubstance Use in 2022

News February 28, 2023
DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances

DEA Concludes Delta-8 and Delta-9 THC-O are Controlled Substances

News February 28, 2023
Federal Court Overturns CSA Conviction Following Ruan

Federal Court Overturns CSA Conviction Following Ruan

News February 23, 2023
Loading...
Print page

© 2026 Center for U.S. Policy. All Rights Reserved.

Close Menu
  • About
  • Issues
  • Initiatives
  • Events
  • Media